NCT04040231 2025-05-13Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in MesotheliomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed10 enrolled
NCT01265433 2024-10-09Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapySellas Life Sciences GroupPhase 2 Completed41 enrolled 12 charts